BOARD OF PHARMACY
Professional and Vocational Licensing Division
Department of Commerce and Consumer Affairs
State of Hawaii
Date: Thursday, July 19, 2018
Time: 9:00 a.m.
Place: Queen Liliuokalani Conference Room, First Floor
King Kalakaua Building
335 Merchant Street
Honolulu, Hawaii 96813
1. Call to Order, Public Notice, Quorum – HRS §92-3 Open Meetings and HAR §16-89-70 Oral Testimony
2. Chair’s Report
a. Announcements and Introductions
b. Approval of the Previous Minutes –June 21, 2018 Meeting
3. Executive Officer’s Report
1) NABP/AACP Districts VI, VII & VII (Annual Meeting, October 14, 17, 2018, Kansas City, Missouri – Ms. Keefe
2) 2018 MPJE State Specific Review and Pre-test Item Selection, September 6-7, 2018, Mount Prospect, Illinois
b. 2018 Legislation
1) SB 2247, SD1, HD2, CD1 Relating to Opioid Antagonists – Authorizes pharmacists to prescribe, dispense, and provide related education on opioid antagonists to individuals at risk of opioid overdose and to family members and caregivers of individuals at risk of opioid overdose without the need for a written, approved collaborative agreement; subject to certain conditions. (CD1) – Governor approved on 7/9/2018
2) HB 2145, HD1, SD1, CD1 Relating to Medication Synchronization - Allows the synchronization of plan participants' medications. Requires plans, policies, contracts, or agreements that are offered by health insurers, mutual benefit societies, and health maintenance organizations and provide prescription drug benefits, to apply prorated daily cost-sharing rates for prescriptions dispensed by network pharmacies for less than a thirty-day supply. (HB2145 CD1) – Transmitted to the Governor on 4/30/2018.
3) HB 1602, HD2, SD1, CD1 Relating to Opioids - Requires the inclusion of a label warning of the risks of addiction and death on the packaging of any opioid drug dispensed by a health care professional or pharmacist. (HB1602 CD1) – Governor approved on 7/9/2018.
4) HB 2739, HD1 – Relating to Health - Establishes a regulated process under which an adult resident of the State with a medically confirmed terminal disease and less than six months to live may choose to obtain a prescription for medication to end the patient's life.
Imposes criminal sanctions for tampering with a patient's request for a prescription or coercing a patient to request a prescription. (HB2739 HD1) – Act 2, SLH 2018
5) SB 2646, SD1, HD3, CD1 – Relating to Prescription Drugs - Requires prescribers of
certain controlled substances to consult the State's Electronic Prescription Accountability System before issuing a prescription for the controlled substance, under certain circumstances. Provides that a violation by a prescriber shall not be subject to criminal penalty provisions but that a violation may be grounds for professional discipline. Repeals on 6/30/2023. (CD1) – Governor approved on 7/9/2018.
6) HB 2384, HD1, SD1 – Relating to the Uniform Controlled Substance Act - Updates Uniform Controlled Substances Act for consistency with federal law. Allows prescription of drugs to patients undergoing medically managed withdrawal, also known as detoxification treatment and maintenance treatment, by practitioners who are properly registered. Governor approved 7/9/2018.
c. Revisions to Pharmacist’s Corresponding Responsibility Guidance Statement - Report
d. Pharmacists Continuing Education Audit – Report
e. Working Conditions Survey – Report
f. State Board of Pharmacy ACPE CPE Activity - Report
a. National Association of Boards of Pharmacy (“NABP”)
• News Roundup – June 2018
b. Is there a limit to the number of times an original, unfilled prescription can be transferred?
5. Chapter 91, HRS – Adjudicatory Matter(s)
a. In the Matter of the Miscellaneous Permit of Wellness Pharmacy, Inc., aka Wellness Health & Pharmaceuticals, Inc.; PHA 2017-86-L, Settlement Agreement Prior to Filing of Petition for Disciplinary Action and Board’s Final order; Exhibits “1” through “3”
6. Applications (The Board may move into Executive Session in accordance with HRS §92-4 and §92-5(a)(1) and (4) “To consider and evaluate personal information relating to individuals applying for licensure;” and “To consult with the Board’s attorney on questions and issues pertaining to the Board’s powers, duties, privileges, immunities, and liabilities;”, Board will vote in Open Meeting.)
a. Ratification Lists
1) Miscellaneous Permit
i. Mailmyprescriptions.com Pharmacy Corporation – Board previously deferred
ii. SterlingRx Inc., dba Sterling Specialty Pharmacy – Board previously deferred
iii. EntirelyPets Pharmacy – Board previously deferred
1. Mark K. Miles
7. Next Meeting: August 16, 2018
Queen Liliuokalani Conference Room
King Kalakaua Building
335 Merchant Street, First Floor
Honolulu, Hawaii 96813
Individuals who require special needs accommodations are invited to call Lee Ann Teshima, Executive Officer, at (808) 586-2695 at least 4 working days in advance of the meeting.
Board of Pharmacy Ratification List for July 19, 2018
PH 4304 ROBERT J <BAUTISTA<
PH 4305 TRENTON K <AOKI<
PH 4306 REBECCA A <KNIGHT<
PH 4307 HAN G <YOO<
PHY 921 4488 HANALEI PLANTATION RD PRINCEVILLE HI 96722 PRINCEVILLE PHARMACY & HEALTH EMPORIUM LLC
PHY 922 87-2070 FARRINGTON HWY STE K WAIANAE HI 96792 5 MINUTE PHARMACY NANAKULI LLC
PHY 923 1881 NANI ST WAILUKU HI 96793 COMMUNITY CLINIC OF MAUI INC